|
Post by Nadica (She/Her) on Jun 22, 2024 23:49:52 GMT
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 - Published May 28, 2020Highlights •SARS-CoV-2 infection induces low IFN-I and -III levels with a moderate ISG response •Strong chemokine expression is consistent across in vitro, ex vivo, and in vivo models •Low innate antiviral defenses and high pro-inflammatory cues contribute to COVID-19 Summary Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19. Graphical Abstract
|
|